𝔖 Bobbio Scriptorium
✦   LIBER   ✦

EGFR Genomic Gain and Aberrant Pathway Signaling in Pancreatic Cancer Patients

✍ Scribed by Ching-Wei D. Tzeng; Andrey Frolov; Natalya Frolova; Nirag C. Jhala; J. Harrison Howard; Selwyn M. Vickers; Donald J. Buchsbaum; Martin J. Heslin; J. Pablo Arnoletti


Book ID
116703367
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
758 KB
Volume
143
Category
Article
ISSN
0022-4804

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Aberrant signaling pathways in pancreati
✍ Angela L. McCleary-Wheeler; Robert McWilliams; Martin E. Fernandez-Zapico πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 452 KB

## Abstract Pancreatic cancer is a devastating disease with historically limited success in treatment and a poor prognosis. Pancreatic cancer appears to have a progressive pathway of development, initiating from well‐described pancreatic intraepithelial neoplasia lesions and concluding with invasiv